Skip to content

Viatris VTRS Q4 2024 Annual earnings

Reported February 27, 2025 · Before market open

Revenue estimate$3.6B
EPS estimate$0.61

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$3.7B
EPS estimate$0.62

Financials

Q4 2024

Income statement

See full
Revenue$3.5B-8.1%
Gross profit$1.2B-23.9%
Net income-$516.5M
EPS (diluted)-$0.43

Balance sheet

See full
Cash & equivalents$736.1M-25.9%
Total debt$14.3B-22.1%
Total equity$18.6B-9.0%
Total assets$41.5B-13.0%

Cash flow

See full
Operating cash flow$482.7M-15.1%
CapEx$140.4M-15.2%
Free cash flow$342.3M-15.1%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$14.86B+14.3%
Enterprise value$28.44B-6.4%
P/S+0.2×

Profitability

See full
Gross margin38.2%-3.6pp
Net margin-4.3%
FCF margin13.4%-2.9pp

Returns & leverage

See full
Return on equity-3.2%
Debt / equity0.8×-0.1×
Current ratio1.6×0.0×

Segments

By product

See full
Brands$2.2B
Generics$1.3B
Lipitor$355.9M-6.3%
Norvasc$166.2M-3.3%
Lyrica ®$127.0M-4.8%

By segment

See full
Developed Markets Segment$2.2B
Greater China$522.3M+1.4%
Emerging Markets Segment$514.0M-18.5%
Japan, Australia and New Zealand Segment$336.3M-9.9%

Versus estimates

Ask the moment Viatris reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Viatris report Q4 2024 earnings?
Viatris (VTRS) reported Q4 2024 earnings on February 27, 2025 before market open.
What were Viatris's Q4 2024 revenue and EPS?
Viatris reported revenue of $3.5B and diluted EPS of $0.54 for Q4 2024.
Did Viatris beat estimates in Q4 2024?
Revenue missed the consensus estimate of $3.6B by $71.9M. EPS missed the consensus estimate of $0.61 by $0.07.
Where can I find Viatris's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001792044-25-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.